[1]
Chakravarthy V, A., Bbv, S. and A, P.K. 2016. METHOD DEVELOPMENT AND VALIDATION OF ULTRAVIOLET-VISIBLE SPECTROSCOPIC METHOD FOR THE ESTIMATION OF HEPATITIS-C DRUGS - DACLATASVIR AND SOFOSBUVIR IN ACTIVE PHARMACEUTICAL INGREDIENT FORM. Asian Journal of Pharmaceutical and Clinical Research. 9, 9 (Dec. 2016), 61–66. DOI:https://doi.org/10.22159/ajpcr.2016.v9s3.14616.